Efficacy and Mechanisms of Energy Medicine to Decrease Chronic Knee Pain in Outpatient Settings

Sponsor
NYU Langone Health (Other)
Overall Status
Recruiting
CT.gov ID
NCT03637595
Collaborator
(none)
30
1
3
42.6
0.7

Study Details

Study Description

Brief Summary

This study will assess the efficacy and mechanisms behind Energy Medicine in reducing chronic knee pain within an outpatient setting. This study will investigate a form of Energy Medicine (EM) performed by a natural solo practitioner, using a standard number of three sessions, which will compare to both positive and negative control groups. The positive control group will receive acupuncture and the negative control group will receive a sham intervention.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Acupuncture
  • Procedure: Enery Medicine Intervention
  • Procedure: Sham Energy Medicine
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Single Group Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Treatment
Official Title:
Efficacy and Mechanisms of Energy Medicine to Decrease Chronic Knee Pain in Outpatient Settings
Actual Study Start Date :
Jun 12, 2019
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Positive Control Group

Acupuncture

Procedure: Acupuncture
3 sessions of acupuncture will be the reference therapy against which the energy medicine intervention is being compared.

Sham Comparator: Negative Control Group

Sham Intervention

Procedure: Sham Energy Medicine
a non-energy trained confederate to be determined from the clinical research coordinators and non traditional volunteers enrolled administering assessments and providing therapeutic company.

Experimental: Energy Medicine (EM) Intervention

Energy Medicine by an energy medicine practitioner

Procedure: Enery Medicine Intervention
3 sessions performed by Energy Medicine practitioner, who will perform an assessment followed by the intervention.

Outcome Measures

Primary Outcome Measures

  1. Pain Level measured by 11- Point Numeric Rating Scale (NRS) [18 Months]

    11 point scale (0-10) asking patient leve of discomfort. A state of no pain is "0" and worst pain is "10"

  2. Pain Level measured by Visual Analog Scale (VAS) [18 Months]

    used for quantification of pain; psychometric response scales used to measure subjective characteristics or attitudes and have been used in the past for a multitude of disorders, as well as in market research and social science investigations, among others

  3. Self Reported Physical Function measured y the Western Ontario and McMaster Universities Ostheoarthritic Index (WOMAC) [18 Months]

    self-administered questionnaire consisting of 24 items divided into 3 subscales:[1] Pain (5 items): during walking, using stairs, in bed, sitting or lying, and standing upright Stiffness (2 items): after first waking and later in the day Physical Function (17 items): using stairs, rising from sitting, standing, bending, walking, getting in / out of a car, shopping, putting on / taking off socks, rising from bed, lying in bed, getting in / out of bath, sitting, getting on / off toilet, heavy domestic duties, light domestic duties

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Presence of knee pain lasting for at least six months

  • No radiation of knee pain

  • No acupuncture treatments in the previous six months

  • Failure to respond completely to the medications given by their orthopedic or pain management specialist

  • Knee pain on most days (4 out of 7 days of the week) with average self-reported severity of 4 or more out of 10 on a numeric rating scale (NRS)

  • Complaints of morning stiffness lasting less than 30 minutes

  • Not be in active physical therapy (PT) for the duration of the trial.

  • Adult patients ≥18 years of age

  • English speaking

Exclusion Criteria:
  • Any concurrent diagnosis of systemic disease

  • Other concurrent treatments such as massage, Acupcunture, PT or any kind of Energy Medicine

  • Bleeding disorder

  • Trypanophobia (fear of needles or injections).

  • Have medical condition that causes difficulty in saliva production/collection (i.e.: Sjogren's Syndrome)

Contacts and Locations

Locations

Site City State Country Postal Code
1 NYU Langone Health New York New York United States 10016

Sponsors and Collaborators

  • NYU Langone Health

Investigators

  • Principal Investigator: Barbara A Siminovich-blok, MD, NYU Langone Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
NYU Langone Health
ClinicalTrials.gov Identifier:
NCT03637595
Other Study ID Numbers:
  • 18-00600
First Posted:
Aug 20, 2018
Last Update Posted:
Mar 21, 2022
Last Verified:
Mar 1, 2022
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No

Study Results

No Results Posted as of Mar 21, 2022